India Gastrointestinal Therapeutics Market, 2025-2033
The gastrointestinal therapeutics market in India is expected to reach a projected revenue of US$ 1,970.3 million by 2033. A compound annual growth rate of 4.8% is expected of India gastrointestinal therapeutics market from 2026 to 2033.
India gastrointestinal therapeutics market highlights
The India gastrointestinal therapeutics market generated a revenue of USD 1,354.8 million in 2025 and is expected to reach USD 1,970.3 million by 2033.
The India market is expected to grow at a CAGR of 4.8% from 2026 to 2033.
In terms of segment, branded was the largest revenue generating drug type in 2025.
Generics is the most lucrative drug type segment registering the fastest growth during the forecast period.
Gastrointestinal therapeutics market data book summary
Market revenue in 2025
USD 1,354.8 million
Market revenue in 2033
USD 1,970.3 million
Growth rate
4.8% (CAGR from 2026 to 2033)
Largest segment
Branded
Fastest growing segment
Generics
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Branded, Generics
Key market players worldwide
AbbVie Inc, AstraZeneca PLC, Bausch Health Companies Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Abbott Laboratories, Janssen Pharmaceuticals, Sun Pharmaceutical Industries, Cipla Ltd DR, Gilead Sciences Inc, Biogen Inc, Organon & Co Ordinary Shares
Other key industry trends
In terms of revenue, India accounted for 3.2% of the global gastrointestinal therapeutics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China gastrointestinal therapeutics market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,394.9 million by 2033.
The gastrointestinal therapeutics market in India is anticipated to grow exponentially due to international collaborations & partnerships to introduce advanced therapeutics into the market. In addition, presence of skilled physicians & workforce and rising healthcare expenditure are some of the major growth factors that can be attributed to the lucrative market growth.
Furthermore, rising prevalence of GERD, IBD, & IBS, growing disposable income, and rising R&D activities for the aforementioned diseases are other factors expected to contribute to growth of the market.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gastrointestinal Therapeutics Market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 60.52% in 2025.
Horizon Databook has segmented the India gastrointestinal therapeutics market based on branded, generics covering the revenue growth of each sub-segment from 2021 to 2033.
The gastrointestinal therapeutics market in India is anticipated to grow exponentially due to international collaborations & partnerships to introduce advanced therapeutics into the market. In addition, presence of skilled physicians & workforce and rising healthcare expenditure are some of the major growth factors that can be attributed to the lucrative market growth.
Furthermore, rising prevalence of GERD, IBD, & IBS, growing disposable income, and rising R&D activities for the aforementioned diseases are other factors expected to contribute to growth of the market.
India Gastrointestinal Therapeutics Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
Branded
Generics
India Gastrointestinal Therapeutics Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
Aminosalicylates
Digestive Enzymes
Proton Pump Inhibitors
Laxatives
Anti-emetics
H2 Antagonists
Anti-diarrheals
Biologics/Biosimilar
Other Drug Classes
India Gastrointestinal Therapeutics Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Injectables
Others Route of Administrations
India Gastrointestinal Therapeutics Market Application Outlook (Revenue, USD Million , 2021-2033)
Crohn's disease
Ulcerative colitis
GERD
IBS
Others Applications
India Gastrointestinal Therapeutics Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Reasons to subscribe to gastrointestinal therapeutics market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of gastrointestinal therapeutics market databook
Our clientele includes a mix of gastrointestinal therapeutics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India gastrointestinal therapeutics market, including forecasts for subscribers. This country databook contains high-level insights into India gastrointestinal therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Gastrointestinal Therapeutics Market, 2021-2033 (US$M)